Work

Mature Results of BEAM/High-Dose Rituximab Vs BEAM/Yttrium-90 Ibritumomab Tiuxetan (Zevalin®) and Autologous Stem Cell Transplantation (ASCT) for Relapsed CD20+ Follicular and Diffuse Large B-Cell Lymphoma: Survival Outcomes and Risk of Secondary Malignancies

Year: 2011

Type: article

Source: Blood

DOI: 10.1182/blood.v118.21.2005.2005

Authors: Lisa Zipp, Rima M Saliba, Rosamar Valverde, Grace-Julia Okoroji, Martin Korbling, Barry I Samuels, Lynne V. Abruzzo, Amin M Alousi, Borje S Andersson, Chitra M Hosing, Bill Erwin, Paolo Anderlini, Uday R Popat, Partow Kebriaei, Homer A Macapinlac, Richard Champlin, Issa F. Khouri

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2586032734

FWCI: 0.672

Cites:

Cited by: 4

Related to: 10